Access to our investigational medicinal product, nizubaglustat
At present, our investigational product is available exclusively through participation in clinical studies. Details about these studies can be found in the relevant section of our website or on ClinicalTrials.gov.
In the future, Azafaros may consider an Early Access or Compassionate Use program in specific circumstances — for example, where there are indications of potential clinical benefit, a lack of satisfactory alternative therapies, or other compelling medical reasons.
Any such program would be implemented in accordance with applicable laws, regulations, and ethical standards in the relevant jurisdictions.